Tech Company M&A Transactions
Gentris Acquisition
On 6/24/2014, Gentris was acquired by Cancer Genetics. The transaction price was $6.3 million.
Transaction Overview
Company Name
Acquired By
Announced On
6/24/2014
Transaction Type
M&A
Amount
$6,250,000
M&A Terms
The purchase price is $3.25 million in cash, $1.5 million in Cancer Genetics stock, and performance-based earn outs up to $1.5 million, according to a news release.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
133 Southcenter Court 400
Morrisville, NC 27560
USA
Morrisville, NC 27560
USA
Phone
Website
Email Address
Overview
Gentris Corporation is a leading global provider of applied clinical pharmacogenomic services and diagnostic product solutions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Amelia Warner
Chief Financial Officer
Pamela Prior
Chief Scientific Officer
Scott Clark
VP - Engineering
John Doyle
Browse more venture capital transactions:
Prev: 6/24/2014: Distractify venture capital transaction
Next: 6/24/2014: OwnerIQ venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record every notable VC transaction. All VC database entries reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs